Brainstorm Cell (Germany) Today
| GHDN Stock | EUR 2.69 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 23
|
Brainstorm Cell is trading at 2.69 as of the 17th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 2.69. Brainstorm Cell has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Brainstorm Cell has reported 15 for 1 split on 1st of October 2024. Equity ratings for Brainstorm Cell Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of November 2022 and ending today, the 17th of November 2024. Click here to learn more.
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. The company has 36.54 M outstanding shares. More on Brainstorm Cell Therapeutics
Moving together with Brainstorm Stock
Moving against Brainstorm Stock
Brainstorm Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Brainstorm Cell's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Brainstorm Cell or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | Chaim Lebovits |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Brainstorm Cell Therapeutics (GHDN) is traded on Frankfurt Exchange in Germany and employs 43 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 74.73 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brainstorm Cell's market, we take the total number of its shares issued and multiply it by Brainstorm Cell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Brainstorm Cell Ther operates under Healthcare sector and is part of Biotechnology industry. The entity has 36.54 M outstanding shares.
Brainstorm Cell Therapeutics has accumulated about 6.22 M in cash with (26.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Check Brainstorm Cell Probability Of Bankruptcy
Ownership AllocationBrainstorm Cell holds a total of 36.54 Million outstanding shares. Brainstorm Cell Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Brainstorm Ownership Details
Brainstorm Cell Ther Risk Profiles
Although Brainstorm Cell's alpha and beta are two of the key measurements used to evaluate Brainstorm Cell's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.34 | |||
| Standard Deviation | 4.03 | |||
| Variance | 16.25 | |||
| Risk Adjusted Performance | (0.09) |
Brainstorm Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Brainstorm Cell without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Brainstorm Cell Corporate Management
Elected by the shareholders, the Brainstorm Cell's board of directors comprises two types of representatives: Brainstorm Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainstorm. The board's role is to monitor Brainstorm Cell's management team and ensure that shareholders' interests are well served. Brainstorm Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainstorm Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yael Gothelf | VP Affairs | Profile | |
| Irit DSc | CoFounder Board | Profile | |
| Antal PearlLendner | VP Counsel | Profile | |
| Daniel Offen | Chief Advisor | Profile | |
| Stacy Lindborg | Exec Officer | Profile |
Additional Information and Resources on Investing in Brainstorm Stock
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.